Palo Alto, CA and Yardley, PA – January 31, 2019 – Altamont Capital Partners (Altamont) today announced the acquisition of Publicis Health Solutions (PHS), a leading pharmaceutical contract commercial services organization, from Publicis Groupe.
PHS is a leader in customized, live channel healthcare sales, service and clinical solutions for pharmaceutical, biotechnology, medical device and diagnostics companies. The business offers these services through a range of brands including Publicis Touchpoint Solutions, PDI, Tardis Medical, Phrequency and CustomPoint Recruiting, with a reputation as a strong partner for its customers in maximizing product commercialization success. As a standalone company with Altamont’s support, PHS will invest to broaden its capabilities and enhance its strategic partnership to help clients navigate increasingly complex market demands. The business will also soon rebrand its services to unite the existing brands under one name which will reflect the integrated offering and forward vision of the business.
As part of the transaction, Altamont’s Operating Partner Michael Griffith will join PHS as its Chief Executive Officer. Griffith is an industry veteran with over 20 years of experience running businesses that provide agency-regulated outsourced services to pharmaceutical clients, most recently as EVP, inVentiv Health and President, Commercial Division. Commenting on the transaction, Griffith said: “PHS has built a reputation for offering best-in-class service and capability to customers seeking to commercialize healthcare products. The partnership with Altamont will enable the PHS organization to further accelerate its growth and impact an even broader set of clients, while retaining the highest quality of service.”
Melissa Francis, Principal at Altamont, added: “We believe the growing pharmaceutical outsourcing industry is one of the most attractive segments of healthcare. We are thrilled to partner with the PHS team and plan to continue to invest in the business to develop a broad suite of go-to-market services for the life sciences industry.” Casey Lynch, Managing Director at Altamont, noted: “PHS represents our eighth corporate carveout, and we believe our depth of carveout experience and industry expertise will support the business as it pursues the exciting growth opportunities that lie ahead.”
About Altamont Capital Partners
Altamont Capital Partners is a private investment firm based in the San Francisco Bay Area with more than $2.5 billion of assets under management. Altamont is focused on investing in middle market businesses where it can partner with leading management teams to help its portfolio companies reach their full potential. The firm’s principals have significant experience building business success stories across a range of industries, including healthcare, consumer/retail, industrials, and financial services.
Brunswick Group on behalf of Altamont Capital Partners